(NASDAQ: CLSD) Clearside Biomedical's forecast annual revenue growth rate of 153.16% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 55.22%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.26%.
Clearside Biomedical's revenue in 2025 is $1,434,000.On average, 4 Wall Street analysts forecast CLSD's revenue for 2025 to be $249,832,943, with the lowest CLSD revenue forecast at $216,029,730, and the highest CLSD revenue forecast at $271,979,876. On average, 4 Wall Street analysts forecast CLSD's revenue for 2026 to be $466,018,090, with the lowest CLSD revenue forecast at $46,625,122, and the highest CLSD revenue forecast at $1,576,706,195.
In 2027, CLSD is forecast to generate $2,258,210,056 in revenue, with the lowest revenue forecast at $1,929,502,949 and the highest revenue forecast at $2,586,917,163.